Resuming aspirin for cardioprotection after GI bleed tied to 38% cut in CV risk
CHICAGO – New data shine a light on the trade-offs involved in resuming low-dose aspirin therapy for secondary cardiovascular prevention following a lower gastrointestinal bleeding event. Going...